C. Schmitt

发表

Electrophysiologic and Antiarrhythmic Effects of D‐Sotalol

J. Brachmann, M. Schweizer, W. Kübler, 1992, Journal of cardiovascular pharmacology.

Electrophysiologic effects of bepridil in patients with refractory ventricular tachycardia assessed by programmed electrical stimulation

W. Kübler, W. Schöls, C. Schmitt, 1990, Clinical cardiology.

Frequency dependence in the action of the class III antiarrhythmic drug dofetilide is modulated by altering L-type calcium current and digitalis glucoside.

A. Schömig, J. Schreieck, S. Weyerbrock, 1998, Journal of cardiovascular pharmacology.

Differential effects of D-sotalol on endocardial and epicardial action potentials of human ventricular myocardium in dilated cardiomyopathy.

C. Schmitt, M. Montero, 1994, Journal of cardiovascular pharmacology.

Differential class III antiarrhythmic effects of ambasilide and dofetilide at different extracellular potassium and pacing frequencies.

A. Schömig, J. Schreieck, S. Weyerbrock, 1996, Journal of cardiovascular pharmacology.

Antiarrhythmic therapy in heart failure

J. Brachmann, M. Schweizer, W. Kübler, 1991 .

Antiarrhythmic Drugs in Heart Failure

J. Brachmann, M. Schweizer, W. Kübler, 1990 .

Identification of patients at high risk for recurrence of sustained ventricular tachycardia after healing of acute myocardial infarction.

J. Brachmann, P. Brugada, H. Wellens, 1992, The American journal of cardiology.

Reverse use-dependent effects of sotalol demonstrated by recording monophasic action potentials of the right ventricle.

J. Brachmann, M. Karch, W. Kübler, 1991, The American journal of cardiology.

Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.

J. Brachmann, W. Kübler, J. Senges, 1987, European heart journal.

Differential effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B.

A. Schömig, B. Zrenner, J. Schreieck, 1997, Journal of cardiovascular electrophysiology.

Conversion of sustained into nonsustained ventricular tachycardia during therapy assessment by programmed ventricular stimulation: criterion for a positive drug effect?

J. Brachmann, W. Schoels, W. Kuebler, 1989, The American journal of cardiology.

Differential Effects of Quinidine on Transmembrane Action Potentials of Normal and Infarcted Canine Purkinje Fibers

J. Brachmann, W. Kübler, T. Beyer, 1992, Journal of cardiovascular pharmacology.

Sotalol Exhibits Reverse Use‐Dependent Action on Monophasic Action Potentials in Normal but Not in Infarcted Canine Ventricular Myocardium

J. Brachmann, M. Karch, W. Kübler, 1992, Journal of cardiovascular pharmacology.

[Combined anti-bradycardia/anti-tachycardia pacemaker-cardioverter-defibrillator systems in patients with recurrent ventricular tachyarrhythmias].

J. Brachmann, W. Schöls, T. Hilbel, 1991, Zeitschrift fur Kardiologie.

Therapy Assessment for Sustained Ventricular Tachyarrhythmias: How Many Electropharmacological Tests are Appropriate?

J. Brachmann, W. Schoels, W. Kuebler, 1990, Pacing and clinical electrophysiology : PACE.

Atrioventricular Nodal Supraventricular Tachycardia with 2:1 Block above the Bundle of His

M. Josephson, John M. Miller, C. Schmitt, 1988, Pacing and clinical electrophysiology : PACE.

Differential Effect of β‐Adrenergic Stimulation on the Frequency‐Dependent Electrophysiologic Actions of the New Class III Antiarrhythmics Dofetilide, Ambasilide, and Chromanol 293.

A. Schömig, B. Zrenner, J. Schreieck, 1997 .

Focal atrial tachycardia

Michael A. E. Schneider, C. Schmitt, Alexander Pustowoit, 2006 .

Effects of lidocaine and procainamide on normal and abnormal intraventricular electrograms during sinus rhythm.

M. Josephson, A. Kadish, F. Marchlinski, 1988, Circulation.

Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment.

J. Brachmann, W. Kübler, J. Senges, 1987, American heart journal.

Predicting ventricular tachycardia cycle length after procainamide by assessing cycle length-dependent changes in paced QRS duration.

M. Josephson, F. Marchlinski, A. Buxton, 1989, Circulation.

Cycle length-dependent effects on normal and abnormal intraventricular electrograms: effect of procainamide.

M. Josephson, A. Kadish, F. Marchlinski, 1988, Journal of the American College of Cardiology.

Ventricular tachycardia initiated solely by reduced pacing rate during routine pacemaker follow‐up

C. Schmitt, E. Alt, M. Coenen, 1996, Clinical cardiology.

[Heart rhythm after conversion of ventricular tachyarrhythmia by internal shock delivery].

J. Brachmann, W. Kübler, W. Saggau, 1994, Zeitschrift fur Kardiologie.

Recording of transmembrane action potentials in chronic ischemic heart disease and dilated cardiomyopathy and the effects of the new class III antiarrhythmic agents D-sotalol and dofetilide.

C. Schmitt, M. Montero, 1996, Journal of cardiovascular pharmacology.

Monophasic Action Potentials

M. Franz, B. Zrenner, C. Schmitt, 1997, Springer Berlin Heidelberg.

Recording of Monophasic Action Potentials with Fractally Coated Electrodes — Experimental and Initial Clinical Results

Michael A. E. Schneider, B. Zrenner, J. Schreieck, 1997 .

Different effects of β-adrenergic stimulation on the prolongation of action potential by Dofetilide and Ambasilide

A. Schömig, M. Korth, C. Schmitt, 1996 .

Identification of patients at high risk for recurrence of sustained ventricular tachycardia after healing of acute myocardial infarction.

J. Brachmann, P. Brugada, H. Wellens, 1992, American Journal of Cardiology.

Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction.

M. Hadamitzky, A. Kastrati, J. Mehilli, 2000, Journal of the American College of Cardiology.

Pros and cons of drugs that prolong ventricular refractoriness.

J. Brachmann, W. Kübler, W. Schöls, 1992, European heart journal.

[Continuous ventricular tachyarrhythmia in patients without detectable organic heart disease: clinical and electrophysiologic findings].

J. Brachmann, W. Kübler, W. Schöls, 1989, Zeitschrift für Kardiologie.

Ventricular late potentials in patients with and without inducible sustained ventricular tachycardia: a combined analysis in the time and frequency domain.

H Dickhaus, J. Brachmann, J. Schramm, 1991, European heart journal.

Rate-independent effects of the new class III antiarrhythmic agent ambasilide on transmembrane action potentials in human ventricular endomyocardium.

A. Schömig, M. Karch, J. Schreieck, 1997, Journal of cardiovascular pharmacology.